Bioject Medical Technologies Inc. (Bioject) is a medical device company. It undertakes the development of needle-free injection therapies to improve the outcome of the administration of liquid medications; pharmaceuticals; vaccines; and biologics. The company develops its products based on its proprietary technology that works by forcing liquid medication at high speed through a tiny orifice held against the skin. Bioject categorizes its products under four groups, namely, Biojector 2000 needle free injection system, ZetaJet system, drug reconstitution system, and needle-free vial adapters. It also develops inexpensive, pre-filled, disposable injection systems in collaboration with its partners. Bioject’s research and development (R&D) activities are focused on the development of DNA-based vaccines and medications. The company markets its products to life sciences market in the Europe Middle East and Africa, Asia Pacific, and North America through an extensive network of distributors. Bioject is headquartered in Tigard, Oregon, the US.
Bioject seeks to commercialize its products through licensing partners on a global basis. The company envisages building its position through internal development, partnerships and strategic collaboration. In line with its strategy, Bioject recently received the Australian Register of Therapeutic Goods Certificate for the Biojector needle-free injection management system (Biojector 2000), the vial transfer spike, and the Bioject ZetaJet needle-free injection therapy system through its local distributor in the region, Meditrend International.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Bioject Medical Technologies Inc.
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio